ClinicalTrials.gov
public full text
Public Domain
Omics Signature in the Diagnosis of Hypertension
The purpose of this study is to assess the validity and usefulness of omics signatures for improved identification and risk stratification of patients with endocrine hypertension and stratification of patients with primary hypertension.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genotype is a predictor of blood pressure variability and relative systemic hypertension risk in sickle cell disease#353183
- Personalised approach to hypertension treatment: Rationale and design of the HYPERMARKER randomised trial#422482
- (123)I-MIBG Scintigraphy-negative Pheochromocytoma without Hypertension Found During Follow-up for Non-functioning Adrenal Incidentaloma.#247703
- Comparison of Blood Pressure Measurement With an Omron HEM-907 Device in a Clinical Setting and a Research Setting#390980
- Metabolic FingerPrinting#898251
Record · ID 852206
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive